155 related articles for article (PubMed ID: 35927660)
1. The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer.
Tang YL; Li GS; Li DM; Tang D; Huang JZ; Feng H; He RQ; Huang ZG; Dang YW; Kong JL; Gan TQ; Zhou HF; Zeng JJ; Chen G
BMC Pulm Med; 2022 Aug; 22(1):300. PubMed ID: 35927660
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract][Full Text] [Related]
3. CDK6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma.
Li GS; Huang ZG; Li DM; Tang YL; Zheng JH; Yang L; Feng Y; Peng JX; Li JX; Tang YX; Zeng NY; Jin MH; Tian J; Liu J; Zhou HF; Chen G; Chen F
Funct Integr Genomics; 2023 Nov; 23(4):332. PubMed ID: 37950078
[TBL] [Abstract][Full Text] [Related]
4. Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer.
Tang D; Li GS; Xu RX; Zhu SY; Luo J; Zheng JH; Liu J; Lu HS; Jin MH; Bao CX; Tian J; Deng WS; Zeng NY; Zhou HF; Kong JL; Chen G
J Oncol; 2022; 2022():2010341. PubMed ID: 35356257
[TBL] [Abstract][Full Text] [Related]
5. ITGB4 Serves as an Identification and Prognosis Marker Associated with Immune Infiltration in Small Cell Lung Carcinoma.
Li GS; Huang ZG; He RQ; Zhang W; Tang YX; Liu ZS; Gan XY; Tang D; Li DM; Tang YL; Zhan YT; Dang YW; Zhou HF; Zheng JH; Jin MH; Tian J; Chen G
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37847361
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
[TBL] [Abstract][Full Text] [Related]
7. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
Kemper M; Schiecke A; Maar H; Nikulin S; Poloznikov A; Galatenko V; Tachezy M; Gebauer F; Lange T; Riecken K; Tonevitsky A; Aigner A; Izbicki J; Schumacher U; Wicklein D
J Exp Clin Cancer Res; 2021 Jun; 40(1):214. PubMed ID: 34174926
[TBL] [Abstract][Full Text] [Related]
8. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes.
Falcioni R; Cimino L; Gentileschi MP; D'Agnano I; Zupi G; Kennel SJ; Sacchi A
Exp Cell Res; 1994 Jan; 210(1):113-22. PubMed ID: 7505746
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.
Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L
Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000
[TBL] [Abstract][Full Text] [Related]
10. Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells.
Wang H; Chen H; Jiang Z; Lin Y; Wang X; Xiang J; Peng J
Pathol Res Pract; 2019 Sep; 215(9):152531. PubMed ID: 31320250
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps.
Müller SJ; Khadhraoui E; Neef NE; Riedel CH; Ernst M
BMC Med Imaging; 2021 Apr; 21(1):70. PubMed ID: 33858368
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
13. Beta 1 integrin expression on human small cell lung cancer cells.
Feldman LE; Shin KC; Natale RB; Todd RF
Cancer Res; 1991 Feb; 51(4):1065-70. PubMed ID: 1705164
[TBL] [Abstract][Full Text] [Related]
14. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer.
He T; Wildey G; McColl K; Savadelis A; Spainhower K; McColl C; Kresak A; Tan AC; Yang M; Abbas A; Dowlati A
Mol Oncol; 2021 Jan; 15(1):195-209. PubMed ID: 33084222
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
17. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
[TBL] [Abstract][Full Text] [Related]
20. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
